Money & Markets
Netflix stock surges 9% after a big earnings beat shows a growing ad businessThe streaming giant added more than five million new paid subscribers, surpassing expectations
Updated October 18, 20242 min read
The streaming giant added more than five million new paid subscribers, surpassing expectations
Plus, Noom launches AI muscle mass scans, and Zealand Pharma''s CEO says next-gen weight loss drugs will have fewer side effects
The streaming said its ad-supported plans accounted for 50% of new signups, helping power a Q3 earnings beat
A new study found that GLP-1 drugs like Ozempic and Mounjaro helped people with substance abuse disorders
The workers were fired for misusing meal allowances meant for office food delivery
Noom has launched a feature that lets users take AI-powered body scans with their smartphones to help track lean muscle mass
The streaming giant will report quarterly earnings this week
A new study from Eli Lilly and the U.K. government will examine how tirzepatide, the active ingredient in Zepbound, impacts a user's employment status
Fox and NBCUniversal have partnered to produce two separate Spanish-language broadcasts of the Super Bowl
A listeria outbreak is affecting products sold in major stores all across the country
Shares in the ride-hailing companies both surged 10%, while Tesla stock sank
Zealand Pharma CEO Adam Steensberg says weight loss drugs that are not based on GLP-1 treatments could potentially have fewer secondary responses
Some top podcasts have landed $100 million deals as the 21-year-old medium goes mainstream
Plus, offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
A trade group filed a lawsuit challenging the FDA's decision to remove the active ingredient in Eli Lilly’s Zepbound from a drug shortage list
The Congressional Budget Office said that if Medicare covered GLP-1 weight loss drugs, federal spending would rise $35 billion by 2034
The program could start as early as 2027 and is meant to help boost drug adherence and health outcomes
The science behind GLP-1 medications like Ozempic and Wegovy, how they compare with other products, their rise to blockbuster weight loss drugs, and much more
WeightWatchers is now offering an off-brand version of Ozempic and Wegovy, starting at $129 a month
Vice President Kamala Harris is proposing that Medicare cover long-term home care services for elders
Kroger is now offering its members subscriptions to Disney+, Hulu, or ESPN+
As the need for accessible mental health support has continued to grow, apps have become a popular way for many people to manage stress and anxiety
Shkreli's 4,000% price increase on a crucial drug led to 2022 pharma industry ban
Spectrum, DirecTV, and Xfinity have all recently announced new partnerships with streaming platforms such as Disney+ and Paramount+